Technical Analysis for OBMP - Oncbiomune Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 0.0034 0.00% 0.0000
OBMP closed unchanged on Friday, August 16, 2019, on 44 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical OBMP trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Volume Surge Other 21.43%
Narrow Range Bar Range Contraction 21.43%
Lower Bollinger Band Walk Weakness 21.43%
New 52 Week Low Weakness 21.43%

Older signals for OBMP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
OncBioMune Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in various cancer therapies. The Company focuses on developing breast and prostate cancer therapeutic vaccines, and a process for the growth of cancer cells and targeted chemotherapies. Its product portfolio consists of approximately three target therapies and a vaccine platform. The Company's lead product, ProscaVax is indicated for prostate cancer. Its focuses on planning Phase II clinical trials of ProscaVax. The Company is also focused on development of its other technologies, such as the paclitaxel-albumin conjugate. It also has a portfolio of targeted therapies, some of which are biosimilars to drugs, including paclitaxel (Abraxane). The Company is focused on the tumor specific immune status of patients both pre and post immunotherapy that uses autologous tumor antigens to immunize patients. The Company focuses on offering Bekunis for constipation and Cirkused for stress.
Medicine Biotechnology RTT Cancer Organic Compounds Chemotherapy Immunotherapy Oncology Prostate Cancer Tumor Antineoplastic Drugs Constipation Targeted Therapy Benzamides Cancer Therapies Benzoates Breast And Prostate Cancer Chemotherapies Paclitaxel
Is OBMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.035
52 Week Low 0.0025
Average Volume 2,238,071
200-Day Moving Average 0.0091
50-Day Moving Average 0.0054
20-Day Moving Average 0.0037
10-Day Moving Average 0.0032
Average True Range 0.001
ADX 12.82
+DI 20.1835
-DI 19.2661
Chandelier Exit (Long, 3 ATRs ) 0.0034
Chandelier Exit (Short, 3 ATRs ) 0.0055
Upper Bollinger Band 0.0049
Lower Bollinger Band 0.0025
Percent B (%b) 0.38
BandWidth 64.864865
MACD Line -0.0006
MACD Signal Line -0.0005
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0046
Resistance 3 (R3) 0.0045 0.0039 0.0044
Resistance 2 (R2) 0.0039 0.0036 0.0040 0.0043
Resistance 1 (R1) 0.0037 0.0034 0.0038 0.0038 0.0043
Pivot Point 0.0031 0.0031 0.0032 0.0032 0.0031
Support 1 (S1) 0.0029 0.0028 0.0030 0.0030 0.0025
Support 2 (S2) 0.0023 0.0026 0.0024 0.0025
Support 3 (S3) 0.0021 0.0023 0.0024
Support 4 (S4) 0.0022